GSK3B and Alzheimer disease: As evidence for this, inhibition of neuroinflammation by minocycline did not affect either GSK‐3β activation or ER stress induced by CSD, despite the fact that it effectively rescued CSD-induced decreases in O-GlcNAc and AD pathogenesis as well as glial activation.